WallStSmart

Cardinal Health Inc (CAH)vsHenry Schein Inc (HSIC)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Cardinal Health Inc generates 1777% more annual revenue ($257.75B vs $13.73B). HSIC leads profitability with a 3.1% profit margin vs 0.7%. CAH appears more attractively valued with a PEG of 1.36. HSIC earns a higher WallStSmart Score of 53/100 (C-).

CAH

Buy

53

out of 100

Grade: C-

Growth: 6.7Profit: 4.5Value: 4.0Quality: 7.5
Piotroski: 6/9Altman Z: 4.52

HSIC

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 5.5Value: 6.7Quality: 5.0
Piotroski: 2/9Altman Z: 2.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CAHSignificantly Overvalued (-54.6%)

Margin of Safety

-54.6%

Fair Value

$179.08

Current Price

$283.87

$104.79 premium

UndervaluedFair: $179.08Overvalued
HSICUndervalued (+48.0%)

Margin of Safety

+48.0%

Fair Value

$157.15

Current Price

$84.96

$72.19 discount

UndervaluedFair: $157.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CAH5 strengths · Avg: 9.0/10
Debt/EquityHealth
-2.9110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.5210/10

Safe zone — low bankruptcy risk

Market CapQuality
$63.40B9/10

Large-cap with strong market position

EPS GrowthGrowth
26.6%8/10

Earnings expanding 26.6% YoY

Free Cash FlowQuality
$1.24B8/10

Generating 1.2B in free cash flow

HSIC2 strengths · Avg: 8.0/10
Price/BookValuation
3.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
26.2%8/10

Earnings expanding 26.2% YoY

Areas to Watch

CAH4 concerns · Avg: 3.3/10
P/E RatioValuation
35.2x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
1.3%3/10

Operating margin of 1.3%

HSIC4 concerns · Avg: 3.5/10
PEG RatioValuation
1.734/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

Debt/EquityHealth
1.233/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CAH

The strongest argument for CAH centers on Debt/Equity, Altman Z-Score, Market Cap. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bull Case : HSIC

The strongest argument for HSIC centers on Price/Book, EPS Growth.

Bear Case : CAH

The primary concerns for CAH are P/E Ratio, Return on Equity, Profit Margin. Thin 0.7% margins leave little buffer for downturns.

Bear Case : HSIC

The primary concerns for HSIC are PEG Ratio, Revenue Growth, Profit Margin. Thin 3.1% margins leave little buffer for downturns.

Key Dynamics to Monitor

HSIC carries more volatility with a beta of 0.86 — expect wider price swings.

CAH is growing revenue faster at 5.5% — sustainability is the question.

CAH generates stronger free cash flow (1.2B), providing more financial flexibility.

Monitor MEDICAL DISTRIBUTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CAH scores higher overall (53/100 vs 53/100). HSIC offers better value entry with a 48.0% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cardinal Health Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Cardinal Health, Inc. is an American multinational health care services company.

Visit Website →

Henry Schein Inc

HEALTHCARE · MEDICAL DISTRIBUTION · USA

Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.

Visit Website →

Want to dig deeper into these stocks?